Magellan Health Inc 's ROA from the third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Magellan Health Inc 's ROA in the third quarter of 2021?
Magellan Health inc achieved a return on average assets (ROA) of 9.17 % in its third quarter of 2021, this is above MGLN's average return on assets of 4.68%.
Magellan Health Inc s assets during the 12 months ending in the third quarter of 2021 are valued at $3 billion

ROA fell compared to the second quarter of 2021, despite the net income growth of % from the second quarter of 2021.

However, within the Healthcare sector 115 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2021 from 810 to 871.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter
Y / Y Total Assets Change	-0.12 %	-3.19 %	0.36 %	39.27 %	6.87 %
Y / Y Net Income Change	-49.03 %	-	52.48 %	1206.51 %	-45.25 %
Net Income (TTM) in million	302	308	392	382	134
Return On Assets (TTM)	9.17 %	9.34 %	11.81 %	11.53 %	4.35 %
MGLN's Total Ranking	# 871	# 810	# 535	# 514	# 1134
Total Assets (TTM) in million	3,353	3,218	3,237	3,361	3,358
Seq. Total Assets Change	4.21 %	-0.57 %	-3.7 %	0.09 %	1.02 %
Seq. Net Income Change	-	-	-89.65 %	2209.03 %	-86.05 %

MGLN's 5 Years Annual ROA >> Back to MGLN Management Effectiveness >> Compare MGLN ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 10
Sector	# 116
Overall	# 852

Return On Assets Statistics
High	Average	Low
11.76 %	4.68 %	0.24 %
(Mar 31 2021)		(Sep 30 2019)

Financial Statements
Magellan Health Inc 's Assets	$ 3,353 million	MGLN's Balance sheet
Magellan Health Inc 's Income	$ 6 million	Quarterly MGLN's Income Statement
MGLN's Income by Division		See MGLN's Income by Division

Annual Return On Assets	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017	(Dec 31 2016) FY 2016
Y / Y Total Assets Change	8.66 %	3.8 %	0.74 %	21.02 %	18.11 %
Total Assets in million	3,360	3,092	2,979	2,957	2,444
Y / Y Net Income Change	583.94 %	131.18 %	-78.05 %	45.33 %	164.01 %
Net Income in million	382	56	24	110	76
Annual Return On Assets	11.38 %	1.81 %	0.81 %	3.72 %	3.1 %

MGLN's 5 Years Annual ROA >> Back to MGLN Management Effectiveness >> Compare MGLN ROA to its Competitors

Comment on MGLN's ROA in the fiscal year ending 2020

In the fiscal year 2020 ROA improved to 11.38 % compared to prior year, due to annual net income growth of 583.94 % to $382.34 million, while value of Magellan Health Inc 's overall assets grew just by 8.66 % to $3,359.86 million, compared to $3,359.86 a year before.

More Return On Assets Ratios
MGLN's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MGLN's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MGLN's Competitors
Subscribers only: Roa for Magellan Health Inc 's Suppliers
Subscribers only: Return On Assets for MGLN's Customers

You may also want to know
MGLN's Roi	MGLN's Inventory Turnover Ratio	MGLN's Growth Rates	MGLN's Dividend Comparisons
	MGLN's Profitability Ratios	MGLN's Asset Turnover Ratio	MGLN's Dividend Growth
MGLN's Roe	MGLN's Valuation Ratios	MGLN's Financial Strength Ratios	MGLN's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2021, within Healthcare Sector	ROA
Nrc Health	24.51 %
Neurocrine Biosciences Inc	23.55 %
Waters Corporation	22.65 %
Hologic Inc	22.59 %
Mettler toledo International Inc	22.56 %
Chemed Corporation	22.00 %
Dyadic International Inc	21.51 %
West Pharmaceutical Services Inc	21.10 %
Tivity Health Inc	20.87 %
Elite Pharmaceuticals Inc	20.46 %
Catalyst Pharmaceuticals Inc	20.25 %
Bionexus Gene Lab Corp	19.69 %
Edwards Lifesciences Corporation	19.52 %
Encision Inc	19.32 %
Lifevantage Corp	19.09 %
Corcept Therapeutics Inc	18.69 %
Organogenesis Holdings Inc	18.48 %
Sana Biotechnology Inc	18.33 %
Vertex Pharmaceuticals Inc	17.87 %
Crispr Therapeutics Ag	17.33 %
Quest Diagnostics Inc	16.74 %
Meridian Bioscience Inc	16.23 %
Lftd Partners Inc	15.71 %
Prothena Corporation Public Limited Company	15.59 %
Hca Healthcare Inc	15.40 %
Procyon Corporation	15.30 %
Sonida Senior Living Inc	15.16 %
Collegium Pharmaceutical Inc	15.08 %
Zoetis Inc	14.35 %
Intuitive Surgical Inc	14.26 %

Date modified: 2026-09-08T15:10:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.